Company:Alamanda Polymers
From HandWiki
 | |
| Type | Private |
|---|---|
| Industry | Basic Materials |
| Founded | October 2007 |
| Headquarters | 1031 Putman Drive, Suite A Huntsville, Alabama 35816 |
Key people | Dr. Willy Vayaboury, Ph.D., Chief Scientist, President Joy Bowman, Chief Technical Officer, Executive Vice President |
| Products | Life Science Technologies and Specialty Chemicals |
| Owner | Willy Vayboury/Joy Bowman |
| Website | alamanda-polymers |
Alamanda Polymers, Inc. is a life sciences company that was formed in 2007 that specializes in formation of polyamino acids to specific chain links for research purposes.
History
Alamanda Polymers was formed in 2007 and produces specialized polyamino acids to specific chain links for research purposes.
Products
- Poly-L-lysine
- Poly-D-lysine
- Poly-L-ornithine
- Poly-L-homoarginine
- Poly-L-arginine
- Poly-L-glutamic acid
- Poly-D-glutamic acid
- Poly-D,L-glutamic acid
- Poly-L-aspartic acid
- PEG-b-poly-L-lysine
- PEG-b-poly-L-glutamic acid
- PEG-b-poly-L-aspartic acid
- Poly(L-Lys)-b-PEG-b-poly(L-Lys)
- Poly(L-Glu)-b-PEG-b-poly(L-Glu)
- Poly(L-Asp)-b-PEG-b-poly(L-Asp)
- PEG-b-poly-D-lysine
- PEG-b-poly-L-glutamic acid
- Poly(L-Glu)-b-PEG-b-poly(L-Glu)
- BOC-NH-PEG-b-poly-L-glutamic acid
Customers
- Novartis
- Genentech
- Lonza
- Merck
- Baxter Healthcare
- Procter and Gamble
- Ciba
- CooperVision
- Roche
- Johnson and Johnson
- Solvay
- Bristol-Myers Squibb
- Stanford University
- Massachusetts Institute of Technology
- UCLA
- Harvard Medical School
- Princeton University
Publications
- "Protein kinase A governs a RhoA–RhoGDI protrusion–retraction pacemaker in migrating cells"
E. Tkachenko, M. Sabouri-Ghomi, O. Pertz, C. Kim, E. Gutierrez, M. Machacek, A. Groisman, G. Danuser, M. H. Ginsberg Nat. Cell Biol. 2011, 13, 660-667.
- "Mitigation of quantum dot cytotoxicity by microencapsulation"
A. Romoser, D. Ritter, R. Majitha, K. E. Meissner, M. McShane, C. M. Sayes PLoS One 2011, 6, e22079.
- "Synthesis and biological evaluation of a polyglutamic acid–dopamine conjugate: a new antiangiogenic agent"
C. Fante, A. Eldar-Boock, R. Satchi-Fainaro, H. M. I. Osborn, F. Greco J. Med. Chem. 2011, 54, 5255-5259.
References
External links
 |
